Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Selection of cord blood unit(s) for transplantation

Abstract

Selection of cord blood (CB) units for transplantation involves combining both cell dose and HLA matching as independent yet overlapping variables. Cell dose and cell yield at the time of transplant are critical given that the transplants are being performed with minimal cells for reliable engraftment. In transplants for malignant disorders, the greater allogenicity and lower relapse rate associated with the less well-matched units balance any benefit of better HLA matching on TRM. The only factor that has repeatedly been associated with improved outcome post CB transplant is cell dose. The CB inventories are rapidly increasing in size and the quality of CB units being banked (larger, better characterized) is improving. With this, some of our current limitations in CB availability will soon become moot. Explorations into CB expansion and multiple CB unit transplants are addressing the limited cell doses attainable with a single CB collection.1, 2, 3, 4 At this point, one must conclude that bigger is better when selecting CB units for transplantation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Shpall Ej E, McNiece Ik I, De Lima M, McMannis Jd J, Robinson S, Peled T et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2004; 10: 738.

    Article  Google Scholar 

  2. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368–376.

    Article  PubMed  Google Scholar 

  3. Peled T, Landau E, Mandel J, Glukhman E, Goudsmid NR, Nagler A et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 2004; 32: 547–555.

    Article  CAS  PubMed  Google Scholar 

  4. Majhail NS, Brunstein CG, Wagner JE . Double umbilical cord blood transplantation. Curr Opin Immunol 2006; 18: 571–575.

    Article  CAS  PubMed  Google Scholar 

  5. Grewal SS, Barker JN, Davies SM, Wagner JE . Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101: 4233–4244.

    Article  CAS  PubMed  Google Scholar 

  6. Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS et al. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 2006; 24: 145–151.

    Article  PubMed  Google Scholar 

  7. Bunin N, Carston M, Wall D, Adams R, Casper J, Kamani N et al. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 2002; 99: 3151–3157.

    Article  CAS  PubMed  Google Scholar 

  8. Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC . A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 2007; 13: 444–453.

    Article  PubMed  Google Scholar 

  9. Chao NJ, Liu CX, Rooney B, Chen BJ, Long GD, Vredenburgh JJ et al. Nonmyeloablative regimen preserves ‘niches’ allowing for peripheral expansion of donor T-cells. Biol Blood Marrow Transplant 2002; 8: 249–256.

    Article  PubMed  Google Scholar 

  10. Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C et al. Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT). Biol Blood Marrow Transplant 2005; 11: 149–160.

    Article  PubMed  Google Scholar 

  11. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–2275.

    Article  CAS  PubMed  Google Scholar 

  12. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007; 13: 82–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007; 110: 3064–3070.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104: 3813–3820.

    Article  CAS  PubMed  Google Scholar 

  15. Kernan N, Carter S, Wagner J, Baxter-Lowe L, Wall D, Kapoor N . Umbilical cord blood transplantation in pediatric patients: results of the prospective, multi-institutional cord blood transplantation study (COBLT). Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 14 (abstract 33).

    Article  Google Scholar 

  16. Roncarolo MG, Bigler M, Martino S, Ciuti E, Tovo PA, Wagner J . Immune functions of cord blood cells before and after transplantation. J Hematother 1996; 5: 157–160.

    Article  CAS  PubMed  Google Scholar 

  17. Han P, Hodge G . Intracellular cytokine production and cytokine receptor interaction of cord mononuclear cells: relevance to cord blood transplantation. Br J Haematol 1999; 107: 450–457.

    Article  CAS  PubMed  Google Scholar 

  18. Rainsford E, Reen DJ . Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol 2002; 116: 702–709.

    Article  CAS  PubMed  Google Scholar 

  19. Gardiner CM, Meara AO, Reen DJ . Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood 1998; 91: 207–213.

    CAS  PubMed  Google Scholar 

  20. Joshi SS, Tarantolo SR, Kuszynski CA, Kessinger A . Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer. Clin Cancer Res 2000; 6: 4351–4358.

    CAS  PubMed  Google Scholar 

  21. El Marsafy S, Dosquet C, Coudert MC, Bensussan A, Carosella E, Gluckman E . Study of cord blood natural killer cell suppressor activity. Eur J Haematol 2001; 66: 215–220.

    Article  CAS  PubMed  Google Scholar 

  22. Hodge S, Hodge G, Flower R, Han P . Cord blood leucocyte expression of functionally significant molecules involved in the regulation of cellular immunity. Scand J Immunol 2001; 53: 72–78.

    Article  CAS  PubMed  Google Scholar 

  23. Nomura A, Takada H, Jin CH, Tanaka T, Ohga S, Hara T . Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response. Exp Hematol 2001; 29: 1169–1176.

    Article  CAS  PubMed  Google Scholar 

  24. Gorin NC, Labopin M, Rocha V, Arcese W, Beksac M, Gluckman E et al. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. Blood 2003; 102: 3043–3051.

    Article  CAS  PubMed  Google Scholar 

  25. Sierra J, Storer B, Hanson J, Bjerke J, Martin P, Petersdorf E . Transplantation of marrow cells from unrelated donor for the treatment of high-risk acute leukemia: the effect of leukemia burden, donor HLA matching, and marrow cell dose. Blood 1997; 89: 4226–4235.

    CAS  PubMed  Google Scholar 

  26. Hurley C, Baxter-Lowe L, Logan B, Karanes C, Anasetti C, Weisdorf D . National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant 2003; 9: 610–615.

    Article  PubMed  Google Scholar 

  27. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576–4583.

    Article  CAS  PubMed  Google Scholar 

  28. Peterdorf E, Kollman C, Hurley C, Dupont P, Nademannee A, Bogovich A . Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program experience. Blood 2001; 98: 2922–2929.

    Article  Google Scholar 

  29. Flomenberg N, Baxter-Lowe L, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M . Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923–1930.

    Article  CAS  PubMed  Google Scholar 

  30. Serna DS, Lee SJ, Zhang MJ, Baker S, Eapen M, Horowitz MM et al. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol 2003; 21: 3754–3760.

    Article  PubMed  Google Scholar 

  31. Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H . Effect of matching class I alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998; 339: 1177–1185.

    Article  CAS  PubMed  Google Scholar 

  32. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P . Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717–2722.

    CAS  PubMed  Google Scholar 

  33. Wall DA, Noffsinger JM, Mueckl KA, Alonso III JM, Regan DM, Johnson CE et al. Feasibility of an obstetrician-based cord blood collection network for unrelated donor umbilical cord blood banking. J Matern Fetal Med 1997; 6: 320–323.

    CAS  PubMed  Google Scholar 

  34. Stevens CE, Gladstone J, Taylor PE, Scaradavou A, Migliaccio AR, Visser J et al. Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood 2002; 100: 2662–2664.

    Article  CAS  PubMed  Google Scholar 

  35. Goodwin HS, Grunzinger LM, Regan DM, McCormick KA, Johnson CE, Oliver DA et al. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential. Cytotherapy 2003; 5: 80–86.

    Article  CAS  PubMed  Google Scholar 

  36. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397–407.

    Article  CAS  PubMed  Google Scholar 

  37. Rubinstein P, Stevens CE . Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Baillieres Best Pract Res Clin Haematol 2000; 13: 565–584.

    Article  CAS  PubMed  Google Scholar 

  38. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  39. Barker J, Scaradavou A, Stevens C, Rubinstein P . Analysis of 608 umbilical cord blood transplants: HLA-match is a critical determinant of transplant-related mortality in the post-engraftment period even in the absence of acute graft-versus-host disease. Blood 2005; 106 (abstract 303).

  40. Gluckman E, Rocha V . Donor selection for unrelated cord blood transplants. Curr Opin Immunol 2006; 18: 565–570.

    Article  CAS  PubMed  Google Scholar 

  41. Kogler G, Enczmann J, Rocha V, Gluckman E, Wernet P . High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 2005; 36: 1033–1041.

    Article  CAS  PubMed  Google Scholar 

  42. van Heeckeren WJ, Fanning LR, Meyerson JH, Fu P, Lazarus HM, Cooper BW et al. Influence of HLA disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplants in adults. Brit J Haematol 2007; 139: 464–474.

    Article  Google Scholar 

  43. Moretta A, Locatelli F, Mingrat G, Rondini G, Montagna D, Comoli P et al. Characterisation of CTL directed towards non-inherited maternal alloantigens in human cord blood. Bone Marrow Transplant 1999; 24: 1161–1166.

    Article  CAS  PubMed  Google Scholar 

  44. van Rood JJ . Double role of HLA in organ transplantation. World J Surg 2000; 24: 823–827.

    Article  CAS  PubMed  Google Scholar 

  45. van Rood JJ, Roelen DL, Claas FH . The effect of noninherited maternal antigens in allogeneic transplantation. Semin Hematol 2005; 42: 104–111.

    Article  CAS  PubMed  Google Scholar 

  46. van Rood JJ, Loberiza Jr FR, Zhang MJ, Oudshoorn M, Claas F, Cairo MS et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002; 99: 1572–1577.

    Article  PubMed  Google Scholar 

  47. Wagner JE, Kurtzberg J . Allogeneic umbilical cord blood transplantation. in: Broxmeyer HE (ed). Cellular Characteristics of Cord Blood and Cord Blood Transplantation. AABB Press: Bethesda, MD, 1998, pp 113–145.

    Google Scholar 

  48. Rocha V, Chastang C, Souillet G, Pasquini R, Plouvier E, Nagler A et al. Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group. Bone Marrow Transplant 1998; 21 (Suppl 3): S59–S62.

    PubMed  Google Scholar 

  49. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073–1082.

    Article  PubMed  Google Scholar 

  50. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T et al. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan. Bone Marrow Transplant 2007; 40: 523–528.

    Article  CAS  PubMed  Google Scholar 

  51. Gluckman E . Cord blood transplantation. Biol Blood Marrow Transplant 2006; 12: 808–812.

    Article  PubMed  Google Scholar 

  52. Barker JN, Weisdorf DJ, Defor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343–1347.

    Article  CAS  PubMed  Google Scholar 

  53. Majhail N, Brunstein C, Wagner J . Double umbilical cord blood transplantation. Curr Opin Immunol 2006; 18: 571–575.

    Article  CAS  PubMed  Google Scholar 

  54. Lister J, Gryn JF, McQueen KL, Harris DT, Rossetti JM, Shadduck RK . Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy. Stem Cells Dev 2007; 16: 177–186.

    Article  CAS  PubMed  Google Scholar 

  55. Chan K, Grimley M, Taylor C, Wall D . Primary graft failure after unrelated donor cord blood transplant: risk factors and management. Blood 2006; 108 (abstract 44): 18a.

  56. Gibbons R . Appendix: G Statistical Report. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. The National Academies Press, 2005, pp 273–282.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D A Wall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wall, D., Chan, K. Selection of cord blood unit(s) for transplantation. Bone Marrow Transplant 42, 1–7 (2008). https://doi.org/10.1038/bmt.2008.100

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.100

Keywords

This article is cited by

Search

Quick links